AEGON ASSET MANAGEMENT UK Plc decreased its position in Xylem Inc. (NYSE:XYL - Free Report) by 11.5% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 129,245 shares of the industrial products company's stock after selling 16,814 shares during the period. AEGON ASSET MANAGEMENT UK Plc owned about 0.06% of Xylem worth $13,089,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. State Street Corp lifted its position in shares of Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after buying an additional 270,972 shares during the last quarter. Perpetual Ltd boosted its stake in Xylem by 10.2% in the third quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company's stock valued at $13,160,000 after buying an additional 11,993 shares in the last quarter. Pinnacle Associates Ltd. boosted its stake in Xylem by 3.6% in the third quarter. Pinnacle Associates Ltd. now owns 274,578 shares of the industrial products company's stock valued at $27,807,000 after buying an additional 9,650 shares in the last quarter. TD Waterhouse Canada Inc. grew its position in Xylem by 1,922.6% in the second quarter. TD Waterhouse Canada Inc. now owns 46,034 shares of the industrial products company's stock valued at $5,400,000 after acquiring an additional 43,758 shares during the last quarter. Finally, XXEC Inc. bought a new position in Xylem in the 2nd quarter valued at approximately $850,841,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Xylem Price Performance
Xylem stock opened at $99.19 on Tuesday. Xylem Inc. has a one year low of $87.40 and a one year high of $152.15. The business has a fifty day moving average price of $103.31 and a 200-day moving average price of $116.27. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.39 and a quick ratio of 1.02. The firm has a market capitalization of $22.75 billion, a P/E ratio of 21.94, a PEG ratio of 1.69 and a beta of 1.01.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). The company had revenue of $2.20 billion during the quarter, compared to analysts' expectations of $2.28 billion. Xylem had a net margin of 11.94% and a return on equity of 12.06%. Xylem's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.37 earnings per share. As a group, equities research analysts forecast that Xylem Inc. will post 5.45 EPS for the current year.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Thursday, August 27th. Xylem's payout ratio is currently 38.05%.
Insider Activity
In related news, Director D Koch bought 11,000 shares of the business's stock in a transaction that occurred on Thursday, October 29th. The stock was bought at an average cost of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the transaction, the director owned 12,247 shares of the company's stock, valued at approximately $1,097,331.20. The trade was a 882.12% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.32% of the company's stock.
Analyst Upgrades and Downgrades
XYL has been the subject of a number of recent research reports. Barclays downgraded Xylem from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $139.00 to $104.00 in a report on Wednesday, October 28th. Wolfe Research started coverage on shares of Xylem in a report on Tuesday, September 15th. They set a "peer perform" rating on the stock. Weiss Ratings lowered Xylem from a "hold (c)" rating to a "sell (d)" rating in a report on Wednesday, October 28th. Royal Bank Of Canada cut their price objective on Xylem from $135.00 to $125.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 28th. Finally, JPMorgan Chase & Co. downgraded Xylem from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $118.00 to $90.00 in a research note on Wednesday, October 28th. Nine equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $121.31.
Check Out Our Latest Analysis on XYL
Xylem Profile
(
Free Report)
Xylem Inc is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure.
The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.
Xylem was established in 2011 when it became an independent company following its spin-off from ITT Corporation.
Featured Stories
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.